I-Mab Biopharma
As of the edition of 20 October 2026, I-Mab Biopharma runs 5 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 3 |
| Stopped | 1 |
| Status not established | 1 |
| Total | 5 |
Where its trials are
- Cancer: 6 trials led
- Digestive system: 3 trials led
- Immune system: 2 trials led